These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16548988)

  • 1. Liquid-based cytology: the evidence is out there?
    Wilson PO
    Cytopathology; 2006 Apr; 17(2):57-9. PubMed ID: 16548988
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to 'Proposed quantitative criteria in cervical cytology to assist the diagnosis and grading of squamous intra-epithelial lesions, as the British Society for Clinical definitions require amendment'.
    Evered A
    Cytopathology; 2006 Apr; 17(2):100; author reply 101. PubMed ID: 16548996
    [No Abstract]   [Full Text] [Related]  

  • 3. Problems of cervical cytology screening.
    Kennedy JD; O'Dwyer EM
    J Ir Med Assoc; 1967 Jan; 60(355):19-22. PubMed ID: 6043196
    [No Abstract]   [Full Text] [Related]  

  • 4. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
    Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE
    Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cytology in Belfast.
    Willis J; Woods J
    J Ir Med Assoc; 1969 May; 62(383):173-4. PubMed ID: 5770861
    [No Abstract]   [Full Text] [Related]  

  • 6. From cost-effectiveness information to decision-making on liquid-based cytology: Mind the gap.
    Legood R; Wolstenholme J; Gray A
    Health Policy; 2009 Feb; 89(2):193-200. PubMed ID: 18619702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automation in cervical cancer screening--part 2: flow systems and other techniques.
    Husain OA; Tucker JH; Roberts BA
    Biomed Eng; 1976 Jun; 11(6):204-10. PubMed ID: 949513
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytology, an increasingly valuable tool in cancer detection.
    Dickie EG
    Hawaii Med J; 1966; 25(4):318-22. PubMed ID: 5948727
    [No Abstract]   [Full Text] [Related]  

  • 9. Transformation zone sampling rate is a useful performance indicator for practitioners collecting cervical samples using SurePath liquid-based cytology system.
    Narine N; Young W
    Cytopathology; 2007 Aug; 18(4):220-4. PubMed ID: 17578516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3d Chilean conference on cytopathology, Chilean Society of Cytology, Valdivia, 17-19 November 1977].
    Rev Chil Obstet Ginecol; 1978; 43(1):1-81. PubMed ID: 754208
    [No Abstract]   [Full Text] [Related]  

  • 11. [Improvement of pretreatment and input preparations of the cellular specimens for the pattern recognition system].
    Matozaki T
    Iyodenshi To Seitai Kogaku; 1983 Feb; 21(1):14-9. PubMed ID: 6632345
    [No Abstract]   [Full Text] [Related]  

  • 12. [The significance of the combined usage of cytology and the HPV test in cervical cancer screening].
    Kina K; Ishi K; Hashizume A; Saeki H; Shiono S; Nagai F; Nojima M
    Rinsho Byori; 2009 Sep; 57(9):913-7. PubMed ID: 19860221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic malignant melanoma of the uterine cervix: first diagnosed on liquid-based cytology.
    Uzüm N; Köse F; Ataoğlu O
    Diagn Cytopathol; 2008 Nov; 36(11):769-72. PubMed ID: 18831038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Exfoliative cytology of portio carcinoma and pregnancy].
    Schmidt AL; Christiaans AP
    Ned Tijdschr Verloskd Gynaecol; 1967 Aug; 67(4):390-4. PubMed ID: 6078671
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of routine exfoliative cytology in patients of the Consulta de Plannificación Familiar].
    Bergher de Bacalao E; Marrero Perez R; Jorgez A; Uzcategui O; Zambrano O; Sczcedrin W
    Rev Obstet Ginecol Venez; 1968; 28(4):559-64. PubMed ID: 5736691
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytology and cytochemistry of exfoliated malignant cells with reference to radiation therapy.
    Malvi SG; Sirsat SM
    Indian J Cancer; 1966 Dec; 3(4):285-97. PubMed ID: 5977882
    [No Abstract]   [Full Text] [Related]  

  • 17. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories.
    Wiener HG; Klinkhamer P; Schenck U; Arbyn M; Bulten J; Bergeron C; Herbert A
    Cytopathology; 2007 Apr; 18(2):67-78. PubMed ID: 17397490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening.
    Bidus MA; Maxwell GL; Kulasingam S; Rose GS; Elkas JC; Chernofsky M; Myers ER
    Obstet Gynecol; 2006 May; 107(5):997-1005. PubMed ID: 16648402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of conventional Papanicolaou smear and SurePath liquid-based cytology in the Copenhagen population screening programme for cervical cancer.
    Kirschner B; Simonsen K; Junge J
    Cytopathology; 2006 Aug; 17(4):187-94. PubMed ID: 16879266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for cervical cancer: controversy and contention or thoughtful analysis.
    Frable WJ
    Cancer; 2007 Jun; 111(3):143-4. PubMed ID: 17487849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.